Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genexa gains exclusive access to AFP's dental imaging devices in Canada:

This article was originally published in Clinica

Executive Summary

Genexa Medical has secured exclusive Canadian rights to market dental imaging systems developed by Elmsford, New York-based AFP Imaging's Dent-X division. Under the terms of the agreement, Genexa will market the NewTom 3-D cone beam computed tomography (CBCT) dental scanners and the EVA+ family of intraoral, dental and digital X-ray sensors to dental practices, imaging centres and hospitals throughout Canada. Genexa, of Edmonton, Alberta, was previously one of several non-exclusive Canadian distributors for Dent-X. AFP said it expects the new agreement with Genexa to generate revenues of $4m in the next 12 months from Canadian sales of the NewTom scanners and EVA dental sensors.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel